AbbVie Inc. — Director's Dealing 2023

Apr 5, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2023-04-03

Reporting Person: Siatis Perry C (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-04-03	Common Stock, $0.01 par value	M	3520	$105.92	Acquired	13897	Direct
2023-04-03	Common Stock, $0.01 par value	S	3520	$160	Disposed	10377	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-04-03	Option (Right to buy)	$105.92	M	3520	Disposed	2031-02-17	Common Stock (3520)	Direct

Footnotes

F1: Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.